- Flip the Script: Rebuttals to AI Replacing CI Analysts
In my last article, I shared this: You’re not competing with AI. You’re competing with leadership’s perception of what AI can do. And it hit home. The comments, messages, and sidebar conversations confirmed it—this perception shift is real. But here’s the bigger issue: What are you going to do about it? If you’re in Competitive…
How Competitive Intelligence Fuels a Winning Authorized Generics Strategy in PharmaIn the ever-evolving landscape of pharmaceuticals, one of the more nuanced and strategic decisions a brand company can make is whether to launch an Authorized Generic (AGx) product. I’ve been fortunate to work closely with clients navigating this decision, and one thing has become abundantly clear: competitive intelligence is a critical enabler of success in…
Tuning into the Right Frequency: How Emotional Intelligence Amplifies Your VoC ProgramRunning a Voice of Customer (VoC) program without emotional intelligence is a bit like trying to tune an old radio with a broken dial. You might catch bits of the song; the static might fade momentarily, but you never quite lock onto the station. You hear the noise, but not the message. That’s how I…
Complete Guide to Competitive IntelligenceFrom seamless sales operations to savvy social media usage, innovative marketing campaigns to effective go-to-market structures, some companies just always seem “one step ahead.” How do they do it? What competitive advantages do these organizations maintain — and are they immutable, something others can aspire to but never surpass? At Proactive Worldwide, we certainly don’t…
Tariffs, Trade Policy, and the Global Pharma Supply Chain: A Competitive Risk AssessmentAs global trade dynamics shift yet again, the pharmaceutical industry is bracing for impact. Recent tariff developments—particularly the reintroduction of sweeping U.S. import duties—are prompting executives across healthcare and life sciences to revisit their sourcing strategies and cost structures. But beyond the headlines lies a more strategic question: How can competitive intelligence help organizations anticipate,…
Why Competitive Intelligence Is My Secret Weapon in the Biosimilars BattleWorking in the pharmaceutical space, I’ve witnessed firsthand how biosimilars have shifted from a theoretical disruption to a real force reshaping market dynamics. Whether you’re on the innovator side trying to protect share or part of a biosimilar team plotting market entry, one thing has become crystal clear to me: you can’t compete in biosimilars…
Rare Disease & Gene Therapy Commercialization: Why Competitive Intelligence Is My Guiding LightWhen I first started working in the rare disease and gene therapy space, I thought the science would be the hardest part to wrap my head around. And don’t get me wrong—it’s complex. But what I didn’t fully appreciate at the time was just how challenging When I first started working in the rare disease…
Why the Neuroscience Resurgence—Especially in Alzheimer’s and Parkinson’s—Is a Call for Smarter Competitive IntelligenceI’ll admit it—there was a time when neuroscience felt like a graveyard of pharma ambitions. I remember the wave of program terminations, the clinical failures, and the retreat from Alzheimer’s and Parkinson’s pipelines that felt almost industry wide. For a while, neuroscience looked like a losing bet. But now? We’re in the middle of a…
From Raw Data to Revenue: How to Monetize Voice of Customer InsightsHave you ever tried to bake bread from scratch? I mean, really from scratch—not just throwing together a boxed mix, but milling the flour, proofing the yeast, kneading the dough, and waiting patiently for it to rise before baking it to golden perfection. It’s a process. And it’s a lot like turning Voice of the…
Need Confidence in Your Next Strategic Move?
When critical decisions carry meaningful business implications, our team helps leaders move forward with greater clarity and confidence.
